公开(公告)号：AU2013276138B2

公开(公告)日：2017-02-23

申请号：AU2013276138

申请日：2013-06-13

Applicant: BASF SE

Inventor： CHIODO TIZIANA ,  HAFNER ANDREAS ,  HINTERMANN TOBIAS ,  SALVADOR BEATE ,  SZELAGIEWICZ MARTIN ,  BLATTER FRITZ ,  SIEBENHAAR BERND ,  VOSSEN MARCUS

IPC: C07D417/12 ,  A61K31/506 ,  A61P35/00

Abstract: The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula 1 (INN: Dasatinib) and a second compound selected from methyl-4-hydroxybenzoate, or nicotinamide, or ethyl gallate, or methyl gallate, or propyl gallate, or ethyl maltol or vanillin, or men- thol, or (1R,2S,5R)-(-)-menthol,as well as to a process for obtaining the same.

公开(公告)号：ES2598168T3

公开(公告)日：2017-01-25

申请号：ES13750525

申请日：2013-08-05

Applicant: BASF SE

Inventor： HAFNER ANDREAS ,  BLATTER FRITZ ,  RÖDEL EVA ,  SZELAGIEWICZ MARTIN ,  CHIODO TIZIANA ,  HINTERMANN TOBIAS ,  SALVADOR BEATE ,  VOSSEN MARCUS

IPC: C07D213/81 ,  A61K31/4196 ,  A61P7/00 ,  C07D249/08

Abstract: Cocristal que comprende un compuesto de fórmula 1 (ácido 4-[3,5-bis(2-hidroxifenil)-1H-1,2,4-triazol-1-il]benzoico;**Fórmula** INN: deferasirox) y un compuesto de fórmula 2 (isonicotinamida; piridina-4-carboxamida)**Fórmula**

公开(公告)号：CA2950485A1

公开(公告)日：2016-01-07

申请号：CA2950485

申请日：2015-06-24

Applicant: BASF SE

Inventor： VIERTELHAUS MARTIN ,  CHIODO TIZIANA ,  SALVADOR BEATE ,  VOSSEN MARCUS ,  HAFNER ANDREAS ,  HINTERMANN TOBIAS ,  SZELAGIEWICZ MARTIN ,  BLATTER FRITZ

IPC: C07D417/12 ,  A61K31/506

Abstract: The present invention primarily relates to multicomponent crystals comprising a compound of formula 1 and a second compound selected from the group consisting of menthol and vanillin. The invention is further related to pharmaceutical compositions comprising such multicomponent crystals. Furthermore, the invention relates to processes for preparing said multicomponent crystals. The invention also relates to several aspects of using said multicomponent crystals or pharmaceutical compositions to treat a disease.

公开(公告)号：MX2014015433A

公开(公告)日：2015-09-16

申请号：MX2014015433

申请日：2013-06-13

Applicant: BASF SE

Inventor： SZELAGIEWICZ MARTIN ,  BLATTER FRITZ ,  CHIODO TIZIANA ,  HAFNER ANDREAS ,  HINTERMANN TOBIAS ,  SALVADOR BEATE ,  SIEBENHAAR BERND ,  VOSSEN MARCUS

IPC: C07D417/12 ,  A61K31/506 ,  A61P35/00

Abstract: La presente invención se refiere a un sistema cristalino de componentes múltiples (co-cristal) que comprende un compuesto de la fórmula I (INN: Dasatinib) y un segundo compuesto seleccionado de metil-4-hidroxibenzoato, o nicotinamida, o galato de etilo, o galato de metilo, o galato de propilo, o etil maltol o vainillina, o mentol, o (1R,2S,5R)-(-), así como a un procedimiento para obtener el mismo.

公开(公告)号：CA2917183A1

公开(公告)日：2015-01-29

申请号：CA2917183

申请日：2014-07-22

Applicant: BASF SE

Inventor： HAFNER ANDREAS ,  BLATTER FRITZ ,  SZELAGIEWICZ MARTIN ,  SIEBENHAAR BERND ,  CHIODO TIZIANA ,  HINTERMANN TOBIAS ,  SALVADOR BEATE ,  VOSSEN MARCUS

IPC: A61K31/506 ,  A61K31/191 ,  A61K31/428 ,  A61K31/455

Abstract: The present invention primarily relates to molecular crystalline substances, preferably salts of Dasatinib in crystalline form, comprising a compound of formula 1, preferably a cation of a compound of formula 1, and a second compound selected from the group consisting of glutaric acid, nicotinic acid and saccharin, preferably an anion thereof. The invention is further related to pharmaceutical compositions comprising such a substance. Furthermore, the invention relates to processes for preparing said substances. The invention also relates to several aspects of using said substances or pharmaceutical compositions to treat a disease.

公开(公告)号：CA2879792A1

公开(公告)日：2014-02-13

申请号：CA2879792

申请日：2013-08-05

Applicant: BASF SE

Inventor： HAFNER ANDREAS ,  BLATTER FRITZ ,  RODEL EVA ,  SZELAGIEWICZ MARTIN ,  CHIODO TIZIANA ,  HINTERMANN TOBIAS ,  SALVADOR BEATE ,  VOSSEN MARCUS

IPC: C07D249/08 ,  A61K31/4196 ,  A61P7/00

Abstract: The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN:Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same.

公开(公告)号：AT491687T

公开(公告)日：2011-01-15

申请号：AT02764577

申请日：2002-06-04

Applicant: BASF SE

Inventor： NESVADBA PETER ,  HINTERMANN TOBIAS ,  KRAMER ANDREAS ,  ZINK MARIE-ODILE ,  BUGNON LUCIENNE

IPC: C07D211/72 ,  C07D211/94 ,  C07F9/59 ,  C08F2/38 ,  C08F4/00 ,  C08F4/04

Abstract: The present invention relates to selected 4-imino-N-alkoxy-polyalkyl-peperidine compounds preparation, a polymerizable composition comprising a) at least one ethylenically unsaturated monomer and b) a 4-imino-N-alkoxy-polyalkyl-piperidine compound. Further aspects of the present invention are a process for polymerizing ethylenically unsaturated monomers, and the use of 4-imino-N-alkoxy-polyalkyl-piperidine compounds for controlled polymerization. The intermediate N-oxyl derivatives, a composition of the N-oxyl derivatives with ethylenically unsaturated monomers and a free radical initiator, as well as a process for polymerization are also subjects of the present invention

公开(公告)号：DE602006009775D1

公开(公告)日：2009-11-26

申请号：DE602006009775

申请日：2006-03-08

Applicant: BASF SE

Inventor： SCHAEFER THOMAS ,  HINTERMANN TOBIAS ,  SCHMIDHALTER BEAT ,  BARDON KRISTINA ,  MURER PETER

IPC: C08L65/00 ,  C07C211/00

Abstract: The present invention relates to polymers comprising a repeating unit of the formula (I), and their use in electronic devices. The polymers according to the invention have excellent 5 solubility in organic solvents and excellent film-forming properties. In addition, high charge carrier mobilities and high temperature stability of the emission color are observed, if the polymers according to the invention are used in polymer light emitting diodes (PLEDs).

公开(公告)号：CA2679526A1

公开(公告)日：2008-09-18

申请号：CA2679526

申请日：2008-02-29

Applicant: BASF SE

Inventor： NESVADBA PETER ,  FREY MARKUS ,  HINTERMANN TOBIAS

IPC: C07D233/30 ,  C07D233/32 ,  C07D241/08 ,  C07D265/32 ,  H01M10/0525 ,  H01M10/0567 ,  H01M10/0568 ,  H01M10/0569 ,  H01M10/36

Abstract: This invention relates to overcharge protection and molecular redox shutt les in rechargeable lithium-ion cells. For this, specific nitroxyls or oxoam monium salts are used in the electrolyte. This invention also relates to a m ethod of producing such lithium-ion cells and to a method of recharging such lithium-ion cells. This invention also pertains to some nitroxyls compounds and oxoammonium salts.

公开(公告)号：ES1221605Y

公开(公告)日：2019-02-28

申请号：ES201890013

申请日：2017-11-02

Applicant: BASF SE ,  BASF CHINA CO LTD

Inventor： HINTERMANN TOBIAS ,  BUJARD PATRICE ,  KOSTRO ANDRE ,  VON MUEHLENEN ADRIAN ,  GARRIDO SEGURA CRISTOBAL

IPC: F21V8/00 ,  F21S11/00